DGAP-News: Nanostart investment BioMers: Growth financing round successfully concluded
(firmenpresse) - DGAP-News: Nanostart AG / Key word(s): Miscellaneous
Nanostart investment BioMers: Growth financing round successfully
concluded
08.11.2011 / 06:00
---------------------------------------------------------------------
- Financing of SGD 6 million
- Holding of Nanostart Singapore-fund remains constant
- Funding to be used for commercial expansion
Frankfurt/Singapore - November 8, 2011 - Singapore Nanostart investment
BioMers has successfully concluded a round of financing for
around SGD 6 million (approximately EUR 3.5 million). Its new investors
include a further venture capital fund and several private investors.
Nanostart is investing pro rata in this financing round and thereby keeping
Nanostart Singapore Early Stage Venture Fund's share in BioMers largely
constant at about 24%.
Andreas Kröll, Managing Director of Nanostart Asia, commented: 'Investors
had a very keen interest in acquiring a stake in BioMers, which confirms
the enormous potential the company has for decisively shaping the market
for esthetic dental correction.'
The new funding is intended for the further expansion of BioMers. This
includes building a new production facility in Singapore, expanding the
sales and marketing team and sales and marketing support activities
focusing on Singapore, the US and selected countries in Europe.
About Nanostart:
Nanostart AG headquartered in the German financial capital
of Frankfurt, is a leading nanotechnology investment company, with
portfolio companies spanning the globe from Silicon Valley to Singapore.
The company provides venture capital financing for nanotechnology companies
in various growth phases with a focus on innovation-driven industries of
the future such as cleantech, life sciences and IT/electronics. Through its
subsidiary Nanostart Asia and the venture capital fund in Singapore,
Nanostart is proud to be the investment partner of the Singaporean
government. For further information, please visit www.nanostart.de.
About BioMers:
BioMers is a medical device company that has developed novel polymer
composite products for numerous biomedical applications. The company's
flagship product is the SimpliClear(TM) braces system, which is the world's
first and only aesthetic solution for all types of orthodontic treatments.
This translucent, almost invisible braces system is customized to each
patient, providing faster and better results. Established in 2005, BioMers
is a spin-off company from the National University of Singapore, where the
technology was invented. BioMers has received seed funding from NUS
Enterprise, venture capital funding from the Nanostart Singapore Early
Stage Venture Fund, and grants from government agencies, including SPRING
Singapore and the Economic Development Board. For more information, please
visit www.biomersbraces.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within Canada, Australia or Japan.
Media contact:
Nanostart AG
Dr. Hans Joachim Duerr
Head of Corporate Communications
Goethestrasse 26-28
D-60313 Frankfurt am Main
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
email: presse(at)nanostart.de
End of Corporate News
---------------------------------------------------------------------
08.11.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
145015 08.11.2011
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 84884
Anzahl Zeichen: 5139
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 219 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Nanostart investment BioMers: Growth financing round successfully concluded"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanostart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
